Page 13 - Simulations Plus News Today

LANCASTER, Calif. — LANCASTER, Calif. — Simulations Plus Inc. on Wednesday reported net income of $4.2 million in its fiscal second quarter. The Lancaster, California-based... | April 5, 2023

Simulations Plus (NASDAQ:SLP – Get Rating) issued an update on its FY23 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $0.63-0.67 for the period, compared to the consensus earnings per share estimate of $0.66. The company issued revenue guidance of $59.3-62.0 million, compared to the consensus revenue estimate of $60.80 […]

Simulations Plus (NASDAQ:SLP – Get Rating) issued an update on its FY23 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.63-0.67 for the period, compared to the consensus estimate of $0.66. The company issued revenue guidance of $59.3-62.0 million, compared to the consensus revenue estimate of $60.80 million. Simulations […]

Simulations Plus (NASDAQ:SLP – Get Rating) is set to issue its quarterly earnings data after the market closes on Wednesday, April 5th. Analysts expect the company to announce earnings of $0.18 per share for the quarter. Simulations Plus has set its FY 2023 guidance at $0.63-$0.67 EPS and its FY23 guidance at $0.63-0.67 EPS.Persons that […]

Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Wednesday, March 29th. The shares were sold at an average price of $42.81, for a total transaction of $856,200.00. Following the completion of the sale, the director now owns 3,895,739 shares […]

Drug discovery services partnership with Sino-American Cancer Foundation focuses on the development of actionable hits against the MTHFD2 target ... | March 28, 2023

Conference call to be on Wednesday, April 5, 2023, at 5 p.m. EDT ... | March 21, 2023

Promising intellectual property resulting from the collaboration with Polish Academy of Sciences will be jointly owned for further development opportunitiesLANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical...

Promising intellectual property resulting from the collaboration with Polish Academy of Sciences will be jointly owned for further development opportunities Simulations Plus, Inc. (Nasdaq: SLP)

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at Oppenheimer’s 33rd Annual Healthcare Conference taking place virtually from March...